Industry

Nomad Health Raises $105 Million to Expand to New Specialties and Address Healthcare Staffing Crisis

New Investor HealthQuest Joins Existing Investors Including Adam Street Partners And Icon Ventures As Digital Marketplace Now Reaches Allied Health Professionals NEW YORK–(BUSINESS WIRE)–Nomad Health, the leading digital marketplace for temporary healthcare jobs, today announced the closing of a $105 million financing co-led by Adams Street Partners and Icon Ventures. New equity investor HealthQuest Capital … [Read more…]

Dxcover Publishes Research Highlighting Effective Early Detection of Pancreatic Cancer Using Infrared Spectroscopy

Study published in Cancers demonstrates how simple, minimally invasive and accurate approaches can represent a powerful aid in earlier detection to improve patients’ prognosis and quality of life GLASGOW, Scotland–(BUSINESS WIRE)–Dxcover Limited, a clinical stage diagnostics company developing spectroscopic liquid biopsy technology for early detection of multiple cancers, today announced findings from a new study … [Read more…]

DotCom Therapy Launches New Wolf+Friends Mobile App, Amplifying Social Network for Families of Children with Special Needs

New app extends the impact of vibrant and established online community by bringing parents together with their peers and expert resources MADISON, Wis.–(BUSINESS WIRE)–#AppLaunch—DotCom Therapy, the most comprehensive pediatric teletherapy provider, today announced the launch of a new mobile application for iOS and Android devices that brings parents of children with special needs together with … [Read more…]

Gilead Endorses The Kigali Declaration On Preventing, Controlling and Eliminating Neglected Tropical Diseases

– By signing the Kigali Declaration, Gilead joins the global community committed to ending neglected tropical diseases by 2030 – FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences today announced that the company has signed onto the Kigali Declaration on neglected tropical diseases (NTDs) which succeeds the London Declaration on NTDs. It was launched on the margins of … [Read more…]

Kuria Therapeutics and SCOHIA PHARMA Announce Strategic Licensing Agreement for Ophthalmic and Dermal Rights to SCO-116, A Novel Nrf2 Activator

– Kuria is granted exclusive worldwide rights to develop, manufacture, and commercialize asset for ocular and dermatologic diseases with localized therapeutic application; SCOHIA PHARMA to receive upfront payment plus up to 67 million USD in potential regulatory, development, and commercial milestones KANAGAWA, Japan & LITTLE ROCK, Ark.–(BUSINESS WIRE)–Kuria Therapeutics, Inc., a US pharmaceutical company developing … [Read more…]

Nomi Health Continues to Subsidize Costs of Covid-19 Testing and Vaccinations for Uninsured Americans

Nearly 100 Days After the End of Federal Funding, Company Upholds Access for the Uninsured as Covid Case Counts Rise Nationwide SALT LAKE CITY–(BUSINESS WIRE)–Nomi Health, the direct healthcare company delivering easy access to low-cost care across the U.S., today announced that it is continuing coverage of Covid-19 testing and vaccinations for anyone with a … [Read more…]

PicnicHealth Closes $60 Million Series C Financing to Deliver New Solutions for Patient-Centered Real-World Data and Evidence Generation

Company plans to add 30 new disease cohorts to its PicnicHealth Research Platform SAN FRANCISCO–(BUSINESS WIRE)–#RWD—PicnicHealth, a patient-centered health technology company, today announced the closing of a $60 million Series C financing led by new investor B Capital Group. Existing investors Felicis Ventures and Amplify Partners also joined the round, bringing the total PicnicHealth has … [Read more…]

Cybin Receives FDA IND Clearance for its Phase 1/2a Clinical Trial Evaluating CYB003 for the Potential Treatment of Major Depressive Disorder

— Marks the first novel psilocybin analog to enter clinical development —— Patient recruitment to commence immediately — — Pharmacokinetic and safety data readout expected in Q4 2022 — TORONTO–(BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (Cybin or the Company), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics™”, today announced that it has received a … [Read more…]

Cellino Announces Appointment of Abhijit Kulkarni, Ph.D. as Chief Operating Officer and Paulette Dillon as Chief Business Officer

– Industry Veterans Expand Company’s Business and Operations Functions CAMBRIDGE, Mass.–(BUSINESS WIRE)–#AI—Cellino Biotech, Inc., an autonomous cell therapy technology platform company, today announced the expansion of its executive leadership team with the appointments of Abhijit (Abhi) Kulkarni, Ph.D. as Chief Operating Officer and Paulette Dillon as Senior Vice President (SVP) and Chief Business Officer. Together, … [Read more…]

Zivo Bioscience Joins Russell Microcap® Index

BLOOMFIELD HILLS, Mich.–(BUSINESS WIRE)–ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today announced that, effective today, June 27, 2022, it has joined the Russell Microcap® Index (^RUMIC) as a result of the 2022 Russell indexes annual … [Read more…]